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ABSTRACT 
The focus of this thesis was to apply advanced statistical methods to the American Heart 
Association Get With The Guidelines-Resuscitation (AHA GWTG-R) registry, a registry data set 
derived from a prospective multi-sites observational study, the American Heart Association’s 
National Registry of Cardiopulmonary Resuscitation (NRCPR). The data comprise 
comprehensive information related to the cardiopulmonary resuscitation (CPR) process, patients’ 
outcome, and characteristics of both the patients and the hospitals. The purpose of the registry 
data is to provide information that can be used to improve the outcomes of sudden cardiac arrest 
(SCA) patients and updates protocol of CPR.  
This thesis has two purposes. The first one is to investigate the relationship between the 
patients’ disease and survival for SCA patients receiving different durations of chest 
compression. The second one is to establish a model for predicting the probability of survival 
according to the duration of CPR. In the clinical setting, a categorized variable may provide 
more meaningful inferences. To explore this option, a Generalized additive model (GAM) was 
used to identify cutoff points for the categorization of chest compression duration. This 
categorized variable was then used for the development of prediction models for survival and the 
Net reclassification index (NRI) was used to select the appropriate predictors for this model. 
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Logistic regression, generalized estimating equations (GEE), and a generalized linear mixed 
model (GLMM) were performed to obtain the estimates of parameters. Thereafter, the 
probability of survival was estimated based on the results of the regression model.  
Comprehensive registry data have been established for many healthcare problems, which 
include many observations and variables. A systematic process to analyze registry data is 
necessary. This thesis used multiple statistical techniques to create meaningful variables, select 
appropriate predictors, fit regression models, and predict the probabilities of outcome. The public 
health significance of this thesis is the identification of subgroups of SCA patients who may 
benefit from prolonged CPR duration and to assess significance of cluster effects in the registry 
data.   
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1.0 INTRODUCTION 
Sudden cardiac arrest (SCA) is defined as sudden, unexpected loss of heart function, breath 
and consciousness. If appropriate treatment is not provided immediately, these patients cannot 
survive. The common causes of SCA include arrhythmia, valvular heart disease, coronary heart 
disease, and so on. The Centers for Disease Control and Prevention (CDC) estimated that 2,000 
SCA deaths occur in the population of individuals that were younger than 25 years old (Kung, 
Hoyert, Xu and Murphy 2008). The general incidence of SCA is hard to estimate. The reported 
incidence of cardiovascular-related, out-of-hospital cardiac arrest (OHCA) in children and 
adolescents in the US ranges between 0.61 and 1.44 per 100,000 pediatric person-years (Meyer, 
et al. 2012).  The age-adjusted risk of SCA was higher in athletic young adults (Corrado, Basso, 
Rizzoli, Schiavon and Thiene 2003). Furthermore, SCA accounted for 0.7% to 3% of pediatric 
hospital admission and up to 5.5% of pediatric intensive care unit (ICU) admissions (Reis, 
Nadkarni, Perondi, Grisi and Berg 2002). Thus the costs of healthcare and rehabilitation 
following SCA lead to significant family, social and medical burden.  
Survival rates have increased in the decades after an improved standard resuscitation 
protocol was implemented (Girotra, et al. 2013, Sutton, et al. 2014). Among the patients with 
SCA, children with cardiac disease had better survival, but those who with trauma had the worst 
outcome (Meert, et al. 2009). The potential factors that are associated with survival of pediatric 
SCA patients have been investigated. A Japanese nationwide population-based study indicated 
that pediatric patients with OHCA can benefit from bystander cardiopulmonary resuscitation 
(CPR) and public access-automated external defibrillator (Akahane, et al. 2013). A prospective 
study based on the National Registry of Cardiopulmonary Resuscitation showed that patients 
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with bradycardia, which is arrhythmia with slow heart rate, were more likely to survive after 
CPR (Donoghue, et al. 2009). A prospective, multinational, observational study investigated 
factors that impact survival on hospital discharge for 502 in-hospital pediatric SCA patients. The 
study concluded that low developmental index, underlying diseases, such as cancer, longer 
compression duration, and more inotropic drug use were associated with mortality of these 
patients (Lopez-Herce, et al. 2013).  
Though longer chest compression duration is considered an indicator of a poor survival 
outcome for SCA patients, some pediatric patients may benefit from prolonged chest 
compression and their characteristics were not thoroughly studied. More medical staffs and drugs 
are required for prolonged CPR. In order to balance the medical cost and survival benefits of 
prolonged CPR for SCA patients, it is important to identify specific characteristics of SCA 
patients whose chance of survival is increased with prolonged chest compressions. This study 
aimed to identify the disease categories of the SCA patients who can benefit from prolonged 
CPR duration and predict the probability of survival based on CPR duration for each disease 
category. I will explore the relationship of the illness categories, chest compression duration, and 
their survival outcomes by using the AHA GWTG-R data (see below). The following process 
illustrates the statistical methods used for analyzing a registry data set to establish a model to 
predict survival of pediatric SCA patients.      
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1.1 RESUSCITATION DATA 
The American Heart Association Get With The Guidelines-Resuscitation (AHA GWTG-R) 
is derived from the American Heart Association’s National Registry of Cardiopulmonary 
Resuscitation (NRCPR). NRCPR is a prospective, multi-site, observational study starting in 1999 
and was incorporated into GWTG in 2010. This is an ongoing study. The primary aim of the 
study is quality improvement of the CPR protocol, so that more lives can be saved through 
appropriate CPR procedure. The program collects resuscitation data from participating hospitals 
and then provides these hospitals with feedback on their resuscitation practice and outcomes of 
patients. Furthermore, new evidence-based guidelines can be developed from the data 
(www.heart.org/resuscitation) (Peberdy, et al. 2003). 
 
1.2 OBJECTIVES 
1.2.1 Survival outcome 
The study aimed to investigate the relationship between illness categories of pediatric SCA 
patients and their outcomes on hospital discharge in each chest compression duration group. 
Furthermore, this study also determined the characteristics of patients and CPR factors that can 
predict the probability of survival.  
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2.0 METHODOLOGY 
2.1 DESIGN 
The AHA GWTG-R is a prospective, multicenter registry of in-hospital cardiac arrest 
(IHCA) and resuscitation events using Utstein-style data reporting (Cummins, et al. 1997, Jacobs, 
et al. 2004). This study included subjects registered in 328 US and Canadian hospitals from 
January 1
st
, 2000 through December 31
st
, 2009.  
 
2.2 SUBJECTS (INCLUSION/EXCLUSION CRITERIA) 
All subjects <18 years of age with pulseless IHCA events were included in this study. The 
subjects must accept at least 1 minute of chest compression. Patients experiencing the events in 
hospitals and in the other locations (outpatient clinics within the hospital, visitors, and inpatients 
of rehabilitation, skilled nursing, and mental health facilities attached to study hospitals) were 
included. The subjects with events that happened outside of the hospital or in the neonatal 
intensive care unit (NICU), delivery room, or nursery were excluded. The subjects with the 
variable illness categories of newborn, obstetric, or other illnesses were excluded, too.  If the 
subjects received more than 180 minutes of chest compression, the chest compression duration 
was winsorized at a pre-determined maximum of 180 minutes to reduce the effects of the 
possible extreme outliers.  
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2.3 MEASURES 
Index events indicated the first cardiopulmonary arrest event during the patient’s 
hospitalization. The illness categories were defined by the characteristics of the patient at the 
time of cardiopulmonary arrest. General medical condition indicated a non-cardiovascular 
medical illness. Medical cardiac patients had a primary diagnosis of a cardiovascular medical 
illness. General surgical patients were enrolled at preoperative status with a general surgical 
illness or at a postoperative status after non-cardiovascular surgery. Surgical cardiac condition 
indicated a postoperative status after cardiovascular surgery. Trauma patients were subjects 
experiencing single or multiple injuries. Patients with “do not attempt resuscitation” before their 
first IHCA were excluded.  
The primary outcome was survival on hospital discharge. Compared to continuous variables, 
categorized variables may be more practical in the clinical setting. Therefore, the chest 
compression duration was categorized based on the results of generalized additive model (GAM).  
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2.4 DATA ANALYSIS 
2.4.1 Generalized Additive Model (GAM) 
A generalized additive model (GAM) was used to determine transformation of the chest 
compression duration variable. This method extends the usual likelihood-based regression 
models and develops its estimation. GAM assumes that the mean of the dependent variable 
depends on an additive predictor through a nonlinear link function. For a linear model with 
covariates,           , the linear function, ∑     
 
 , of the likelihood-based regression model 
is replaced by an smooth function, ∑   (  )
 
 , that defines the additive component.  
 
For a generalized linear model (GLM),  { }     ∑   (  )
 
   , where   is the conditional 
expectation of    given        . Therefore, GAM is  { }        ∑   (  )
 
   . 
 
The local scoring algorithm and the weighted backfitting algorithm are used to estimate the 
  ( )’s. The algorithms find new estimates of the functions by smoothing the partial residuals till 
the partial functions converge. The local scoring algorithm is used when the dependent variables 
are categorical, and the backfitting algorithm is used for the model with continuous dependent 
variables. Any nonparametric smoothing method, such as lowess and B-spline, can be used to 
estimate the   ( )’s. This procedure can reduce a multiple regression to a series of two-
dimensional partial regression problems. The results can be plotted on a two dimensional graph 
to show the partial effects of each     on Y (Hastie and Tibshirani 1986). 
The GAM provides a nonparametric method to see the relationship between the predictors 
and the outcome. In a clinical setting, categorizing some continuous variables may be more 
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applicable, especially for predicting clinical outcomes. Therefore, information obtained from 
GAM can be used to determine appropriate cutoff points based on the data. In GAM, the 
relationship between X’s, the horizontal axis, and s(X), the vertical axis, can be plotted.  The line 
for s(X)= 0 indicates the average value of the covariate. The average-risk cutoff points are those 
x’s   X, such that s(x)=0. Furthermore, the points where the slopes change are the extra cut-off 
points. The selection of the extra cut-off points are based on the graphical visualization of the 
slopes and the clinical significance (Barrio, Arostegui, Quintana and Group 2013).      
In this analysis, only one predictor, a continuous variable of chest compression duration, 
was used in the GAM. And the survival status on discharge was the dependent variable. 
Categorization of the continuous chest compression duration variable was determined by the 
GAM method and expert opinions.  
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2.4.2 Net Reclassification Index (NRI) 
The AHA GWTG-R includes variables recording clinical and administrative data in each 
resuscitation event. The purpose of this study is to predict the probability of survival according to 
the characteristics of subjects. In order to determine the appropriate covariates for the models, 
the net reclassification index (NRI) was used. This method quantifies whether a new independent 
variable can provide a clinically relevant improvement in the prediction of the dependent 
variable. The model with established predictors is indicated as the “old” model. The model with 
one additional new predictor is denoted as the “new” model. The NRI is estimated by the 
following equations: 
 
Event NRI:      NRIe= P (up|event) – P (down|event), where 
{
                                                                                      
                                                                                                         
                                                                                                                              
                                                                                                                           
 
Non-event NRI:      NRIne= P (up|noevent) – P (down|noevent) 
An NRI is the sum of event NRI and non-event NRI, yielding 
NRI= P (up|event) - P (down|event) + P (down|nonevent) - P (up|nonevent).  
 
If the new predictor increases the predicted risk for an event and decreases the predicted risk 
for a non-event, P (up|event) and P (down|event) provide the positive components of the NRI. 
However, the risk of the event moving down and the risk of the non-event moving up indicate 
that the new predictor compromises the prediction ability of the model (Pencina, D'Agostino, 
D'Agostino and Vasan 2008).  
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The potential predictors were selected based on the results of descriptive statistics and 
opinions of experts, the emergent physicians. The most important predictors, determined by 
physicians, formed the basic model. A new predictor was added into the basic model, and NRI 
was performed for the new predictor. If the new predictor significantly increased the prediction 
power of the survival outcome, the new predictor was incorporated into the old model and 
formed the new basic model. If the new predictor could not improve prediction of the survival 
outcome, the predictor was dropped. The chosen predictors were then used for further analyses.  
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2.4.3 Logistic Regression Model 
The outcome is a binary variable and logistic regression is the approach of choice in this 
setting. One goal of the study was to model the conditional probability P(Y= 1 | X= x) as a 
function of x.  One assumption of a logistic regression model is the independence of every 
subject or observation. The unknown parameters in the function were estimated by maximum 
likelihood.  
 
The general form of logistic regression model is  
     ( [    |  ])     (
 (  )
   (  )
)      , where {
 (         )               
 (        )                   
 (       )                             
 . 
Solving for p(Xi), the probability of the event occurring, the result is 
 (  )  
    
      
  
 
    (   )
 . 
 
In this analysis, the major outcome was survival of the subjects. The first purpose was to test 
whether patients in some illness categories had higher odds of survival in a specific compression 
duration category. The hypothesis was that the odds of survival are not the same for patients with 
different illness categories and in different chest compression duration categories. In other words, 
compression duration categories were the effect modifier of the relationship between illness 
categories and survival. The interaction of illness and compression duration categories was 
included in the regression model.  
The second purpose was to predict the probability of survival for patients with different 
illness categories based on the chest compression duration. This predictive model was 
established based on the results of the NRI. After the values of the parameters were estimated, 
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the probability of survival for chest compression duration from 0 minute through 180 minutes 
was calculated. The average values of the other covariates were used in calculating the 
probability of survival. The prediction indicated the probability of survival for an average patient 
receiving chest compression from 0 through 180 minutes.    
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2.4.4 Generalized Estimating Equation Model (GEE) 
Though the procedure of CPR has been established and standardized, the survival of SCA 
subjects may depend on the quality of critical care within the hospitals. Therefore, the survival of 
subjects within the same hospital may be correlated. To obtain the population average estimates 
by considering the correlated data within each hospital, a generalized estimating equation (GEE) 
model was used (Zeger and Liang 1986). The outcome and covariates were the same as those in 
the logistic model.    
 
The GEE model:      ( [     |   ])      , {
               
               
,  
 
Marginal mean (population-average mean):      (   |   )   (     |   )  
 
Variance-covariance matrix for correlated data (N clusters and J observation per cluster): 
V= (
    
   
    
) 
= (
   (       )   
   
     (       )
),     j, k=1, …, J 
= (
   
   
    
   
  
   
     
   
    
   
) 
V=V(Y): a N×N variance-covariance matrix of the dependent variable 
Ai: a J×J diagonal matrix with V(ij) as the jth diagonal element 
Ri: a J×J working correlation matrix 
13 
 
 : a overdispersion parameter 
 
Working variance-covariance matrix for Yi is equal to Vi=   
   
    
   
 
 
Common working correlation structure: 
Independence, where Rjk=0 
      [
   
   
   
] 
Exchangeable, where Rjk=ρ 
      [
   
   
   
] 
Autoregressive, AR(1), where Rjk=ρ
|j-k| 
      [
      
   
      
] 
Unstructured, where Rjk=ρjk 
      [
      
   
      
] 
 
The major assumption of the GEE model is that the data satisfy the missing completely at 
random (MCAR) assumption. The registry data were established by the trained coordinators who 
record all required variables during resuscitation and the following clinical results. The data 
collection procedure was consistent within each hospital. Therefore, the missing values were not 
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likely to be associated with covariates and outcomes. For the purposes of this analysis, we 
assume that the MCAR assumption was not violated.  
The purpose of the analysis was to compare the GEE model to the logistic regression model, 
so the covariates in the models were the same. Quasilikelihood under the independence model 
criterion (QIC) was used to determine the appropriate working correlation structure (Pan 2001).  
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2.4.5 Generalized Linear Mixed Model (GLMM) 
The third model is the generalized linear mixed model (GLMM). Contrary to GEE that 
estimates a population-average mean, GLMM estimates a conditional mean (Williams 1982).  
 
The general form of the model is  
 ⏞
   
  ⏟
   
 ⏟
   
⏞   
   
  ⏟
   
 ⏟
   
⏞  
   
  ⏞
   
 .   
      ( [   | ])     (
 ( )
   ( )
)       ,  
  ∑   
 
   , where j: 1-q clusters  
   (   ), where       
  for a random intercept. 
GLMM uses a logistic link function for a binary outcome. 
 
 
 
This registry data set was established through participating hospitals, so this study can be 
considered as a clustered study design. A random intercept effect was applied to this model. The 
covariates in GLMM were the same as those in the logistic regression model.  
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3.0 RESULTS 
3.1 DEMOGRAPHIC CHARACTERISTICS 
A total of 2,564 subjects were eligible in this study. Figure 1 showed the distribution of 
chest compression duration. More than 50% of the subjects received less than 25 minutes of 
chest compression. Table 1 showed the demographic characteristics of the subjects. More than 
40% of patients were in the general medical group. Only 194 subjects were in a general surgical 
group. Overall, 40% of the subjects received chest compression for less than 16 minutes. For 
subjects with general surgical condition or with trauma, almost half of them had less than 16 
minutes of chest compression. Compared to the other patients, a higher proportion of subjects 
with cardiac diseases accepted longer chest compression duration. Nearly half of the patients 
with a surgical cardiac condition were younger than 1 month; however, more than 50% of trauma 
patients were 8 years of age and older. Gender was not significantly different across all illness 
groups. Most of the SCA patients were inpatients of healthcare facilities. Most SCA events 
happened in the intensive care unit (ICU). In all illness categories, patients mainly presented 
hypotension or hypoperfusion. Most patients required invasive airway establishment and 
mechanical ventilator support, especially for those patients with a surgical or traumatic condition. 
Twenty-three percent of patients with a surgical cardiac condition needed a pacemaker. Pre-
existing respiratory insufficiency and hypotension/hypoperfusion were common across all illness 
groups. Otherwise, incidence of other pre-existing health conditions was low. More than 40% of 
traumatic patients were sent to the emergency department (ED) during the weekend.  For patients 
with a general medical or a general surgical condition, their first pulseless rhythm was mainly 
presented as asystole; however, the trauma and surgical cardiac patients mainly experienced 
pulseless electrical activity (PEA). More than 80% of all patients used epinephrine, but other 
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vasopressors were not administered for most patients.  More patients with a surgical cardiac 
condition required invasive procedures, such as an invasive airway insertion, pacemaker, and 
continuous sedation.  
More than 70% of SCA patients died after CPR. Table 2 showed the outcomes of patients 
with individual illness categories. Patients with surgical condition had higher survival rates, but 
only 10% of trauma patients survived. Table 3 showed the survival rate of SCA patients in each 
chest compression duration category. Forty-six percent of the patients receiving less than 16 
minutes of chest compression duration survived. The survival rates were similar for patients 
receiving 16-35 minutes and longer than 35 minutes of chest compression duration.  
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Figure 1. Distribution of Chest Compression Duration 
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Table 1. Demographic Characteristics 
 
   Illness Category   
  All (N=2,564) Medical, 
cardiac 
(N=444) 
General, 
medical 
(N=1,111) 
Surgical, 
cardiac 
(N=541) 
General, 
surgical 
(N=194) 
Trauma 
(N=274) 
  
  N(%) N(%) N(%) N(%) N(%) N(%) P-value 
Chest compression group <0.001 
     0-15 1038 (40.48) 157 (35.36) 434 (39.06) 211 (39) 94 (48.45) 142 (51.82)   
     16-35 772 (30.11) 149 (33.56) 360 (32.4) 129 (23.84) 48 (24.74) 86 (31.39)   
     >35 754 (29.41) 138 (31.08) 317 (28.53) 201 (37.15) 52 (26.8) 46 (16.79)   
Age group <0.001 
     <1 month 498 (19.42) 80 (18.02) 116 (10.44) 269 (49.72) 28 (14.43) 5 (1.82)   
     1 month - <1 year 682 (26.6) 149 (33.56) 298 (26.82) 152 (28.1) 56 (28.87) 27 (9.85)   
     1 yr - <8yr 659 (25.7) 124 (27.93) 331 (29.79) 73 (13.49) 50 (25.77) 81 (29.56)   
     8 yr - <18 yr 725 (28.28) 91 (20.5) 366 (32.94) 47 (8.69) 60 (30.93) 161 (58.76)   
Gender 0.189 
     Male 1457 (56.83) 237 (53.38) 624 (56.17) 312 (57.67) 113 (58.25) 171 (62.41)   
     Female 1107 (43.17) 207 (46.62) 487 (43.83) 229 (42.33) 81 (41.75) 103 (37.59)   
Race <0.001 
     White 1391 (54.79) 237 (53.86) 567 (51.59) 324 (60.56) 116 (60.10) 147 (50.04)   
     Black 560 (22.06) 93 (21.14) 281 (25.57) 83 (15.51) 38 (19.69) 65 (23.90)   
     Asian/Pacific  61 (2.40) 12 (2.73) 26 (2.37) 10 (1.87) 6 (3.11) 7 (2.57)   
     Native American  27 (1.06) 7 (1.59) 9 (0.82) 4 (0.75) 1 (0.52) 6 (2.21)   
     Other 240 (9.45) 58 (13.18) 102 (9.28) 47 (8.79) 15 (7.77) 18 (6.62)   
     Unknown 260 (10.24) 33 (7.50) 114 (10.37) 67 (12.52) 17 (8.81) 29 (10.66)   
20 
 
Hispanic 0.01 
     No 1897 (81.35) 311 (78.73) 823 (82.71) 401 (79.56) 142 (78.45) 220 (85.60)   
     Yes 435 (18.65) 84 (21.27) 172 (17.29) 103 (20.44) 39 (21.55) 37 (14.40)   
Event Location <0.001 
     ICU 1717 (66.97) 276 (62.16) 675 (60.76) 476 (87.99) 118 (60.82) 172 (62.77)   
     Emergency 367 (14.31) 172 (62.77) 216 (19.44) 2 (0.37) 2 (1.03) 68 (24.82)   
     General Inpatient 265 (10.34) 42 (9.46) 166 (14.94) 25 (4.62) 26 (13.4) 6 (2.19)   
     Procedure room 144 (5.62) 32 (7.21) 24 (2.16) 21 (3.88) 45 (23.2) 22 (8.03)   
     Others 71 (2.77) 15 (3.38) 30 (2.7) 17 (3.14) 3 (1.55) 6 (2.19)   
Time of Day (Night=11pm-6am/Day=6:01am-10:59pm) 0.257 
     Day 1711 (66.73) 297 (66.89) 736 (66.25) 367 (67.84) 140 (72.16) 171 (62.41)   
     night 853 (33.27) 147 (33.11) 375 (33.75) 174 (32.16) 54 (27.84) 103 (37.59)   
Weekend  (Fri 11pm-Mon 7am) <0.001 
     No 1676 (65.37) 285 (64.19) 715 (64.36) 388 (71.72) 138 (71.13) 150 (54.74)   
     Yes 888 (34.63) 159 (35.81) 396 (35.64) 153 (28.28) 56 (28.87) 124 (45.26)   
SubjectType <0.001 
     Hospital Inpatient  2145 (83.66) 345 (77.7) 877 (78.94) 533 (98.52) 190 (97.94) 200 (72.99)   
     Emergency Dep 372 (14.51) 80 (18.02) 217 (19.53) 2 (0.37) 2 (1.03) 71 (25.91)   
     Outpatient 32 (1.25) 16 (3.6) 10 (0.9) 4 (0.74) 2 (1.03)  0 (0.00)   
     Visitor or Employee 2 (0.08) 1 (0.23) 1 (0.09)  0 (0.00)  0 (0.00)  0 (0.00)   
     Rehab Inpatient 2 (0.08)  0 (0.00) 2 (0.18)  0 (0.00)  0 (0.00)  0 (0.00)   
     Skilled Nursing 
Inpatient 
10 (0.39) 2 (0.45) 3 (0.27) 2 (0.37)  0 (0.00) 3 (1.09)   
     Mental Health 
Inpatient 
1 (0.04)  0 (0.00) 1 (0.09)  0 (0.00)  0 (0.00)  0 (0.00)   
Witnessed <0.001 
     No 208 (8.11) 56 (12.61) 109 (9.81) 13 (2.4) 14 (7.22) 16 (5.84)   
     Yes 2356 (91.89) 388 (87.39) 1002 (90.19) 528 (97.6) 180 (92.78) 258 (94.16)   
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Witness OR monitor <0.001 
     No 107 (4.17) 32 (7.21) 62 (5.58) 3 (0.55) 5 (2.58) 5 (1.82)   
     Yes 2457 (95.83) 412 (92.79) 1049 (94.42) 538 (99.45) 189 (97.42) 269 (98.18)   
Cause: Drug Overdose  0.006 
     No 2550 (99.45) 443 (99.77) 1098 (98.83) 541 (100) 194 (100) 274 (100)   
     Yes 14 (0.55) 1 (0.23) 13 (1.17)  0 (0.00)  0 (0.00)  0 (0.00)   
Cause: Hypotension/Hypoperfusion <0.001 
     No 1177 (45.9) 222 (50) 567 (51.04) 194 (35.86) 96 (49.48) 98 (35.77)   
     Yes 1387 (54.1) 222 (50) 544 (48.96) 347 (64.14) 98 (50.52) 176 (64.23)   
Cause: Acute Pulmonary Edema 0.259 
     No 2500 (97.5) 434 (97.75) 1076 (96.85) 533 (98.52) 191 (98.45) 266 (97.08)   
     Yes 64 (2.5) 10 (2.25) 35 (3.15) 8 (1.48) 3 (1.55) 8 (2.92)   
Cause: Metabolic Electrolyte Abnormality 0.001 
     No 2192 (85.49) 396 (89.19) 921 (82.9) 482 (89.09) 165 (85.05) 228 (83.21)   
     Yes 372 (14.51) 48 (10.81) 190 (17.1) 59 (10.91) 29 (14.95) 46 (16.79)   
Cause: Invasive Airway Displacement 0.004 
     No 2525 (98.48) 440 (99.1) 1093 (98.38) 536 (99.08) 185 (95.36) 271 (98.91)   
     Yes 39 (1.52) 4 (0.9) 18 (1.62) 5 (0.92) 9 (4.64) 3 (1.09)   
Cause: Inadequate Natural Airway <0.001 
     No 2479 (96.68) 435 (97.97) 1066 (95.95) 531 (98.15) 178 (91.75) 269 (98.18)   
     Yes 85 (3.32) 9 (2.03) 45 (4.05) 10 (1.85) 16 (8.25) 5 (1.82)   
Cause: Inadequate Invasive Airway 0.043 
     No 2496 (97.35) 437 (98.42) 1079 (97.12) 530 (97.97) 183 (94.33) 267 (97.45)   
     Yes 68 (2.65) 7 (1.58) 32 (2.88) 11 (2.03) 11 (5.67) 7 (2.55)   
Cause: Conscious Sedation 0.078 
     No 2545 (99.26) 439 (98.87) 1107 (99.64) 538 (99.45) 190 (97.94) 271 (98.91)   
     Yes 19 (0.74) 5 (1.13) 4 (0.36) 3 (0.55) 4 (2.06) 3 (1.09)   
Cause: Hypothermia 0.007 
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     No 2514 (98.05) 436 (98.2) 1090 (98.11) 535 (98.89) 192 (98.97) 261 (95.26)   
     Yes 50 (1.95) 8 (1.8) 21 (1.89) 6 (1.11) 2 (1.03) 13 (4.74)   
Pre-existing condition: Cardiac Malformation Acyanotic <0.001 
     No 2477 (96.61) 431 (97.07) 1098 (98.83) 486 (89.83) 188 (96.91) 274 (100)   
     Yes 87 (3.39) 13 (2.93) 13 (1.17) 55 (10.17) 6 (3.09)  0 (0.00)   
Pre-existing condition: Cardiac Malformation Cyanotic <0.001 
     No 2364 (92.2) 392 (88.29) 1102 (99.19) 403 (74.49) 193 (99.48) 274 (100)   
     Yes 200 (7.8) 52 (11.71) 9 (0.81) 138 (25.51) 1 (0.52)  0 (0.00)   
Pre-existing condition: Hypotension/Hypoperfusion <0.001 
     No 1547 (60.34) 303 (68.24) 734 (66.07) 250 (46.21) 117 (60.31) 143 (52.19)   
     Yes 1017 (39.66) 141 (31.76) 377 (33.93) 291 (53.79) 77 (39.69) 131 (47.81)   
Pre-existing condition: Respiratory Insufficiency <0.001 
     No 1044 (40.72) 197 (44.37) 413 (37.17) 210 (38.82) 78 (40.21) 146 (53.28)   
     Yes 1520 (59.28) 247 (55.63) 698 (62.83) 331 (61.18) 116 (59.79) 128 (46.72)   
Pre-existing condition: Renal Insufficiency <0.001 
     No 2307 (89.98) 409 (92.12) 962 (86.59) 501 (92.61) 174 (89.69) 261 (95.26)   
     Yes 257 (10.02) 35 (7.88) 149 (13.41) 40 (7.39) 20 (10.31) 13 (4.74)   
Pre-existing condition: Hepatic Insufficiency <0.001 
     No 2440 (95.16) 431 (97.07) 1042 (93.79) 527 (97.41) 174 (89.69) 266 (97.08)   
     Yes 124 (4.84) 13 (2.93) 69 (6.21) 14 (2.59) 20 (10.31) 8 (2.92)   
Pre-existing condition: Metabolic ElectrolyteAbn 0.02 
     No 2065 (80.54) 372 (83.78) 862 (77.59) 449 (82.99) 157 (80.93) 225 (82.12)   
     Yes 499 (19.46) 72 (16.22) 249 (22.41) 92 (17.01) 37 (19.07) 49 (17.88)   
Pre-existing condition: Diabetes Mellitus <0.001 
     No 2522 (98.36) 433 (97.52) 1083 (97.48) 539 (99.63) 193 (99.48) 274 (100)   
     Yes 42 (1.64) 11 (2.48) 28 (2.52) 2 (0.37) 1 (0.52)  0 (0.00)   
Pre-existing condition: Baseline Depression In CNS Function <0.001 
     No 2134 (83.23) 403 (90.77) 837 (75.34) 520 (96.12) 155 (79.9) 219 (79.93)   
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     Yes 430 (16.77) 41 (9.23) 274 (24.66) 21 (3.88) 39 (20.1) 55 (20.07)   
Pre-existing condition: Pneumonia <0.001 
     No 2329 (90.83) 410 (92.34) 940 (84.61) 526 (97.23) 187 (96.39) 266 (97.08)   
     Yes 235 (9.17) 34 (7.66) 171 (15.39) 15 (2.77) 7 (3.61) 8 (2.92)   
Pre-existing condition: Septicemia <0.001 
     No 2183 (85.14) 391 (88.06) 869 (78.22) 493 (91.13) 163 (84.02) 267 (97.45)   
     Yes 381 (14.86) 53 (11.94) 242 (21.78) 48 (8.87) 31 (15.98) 7 (2.55)   
Pre-existing condition: Major Trauma <0.001 
     No 2276 (88.77) 442 (99.55) 1094 (98.47) 541 (100) 182 (93.81) 17 (6.2)   
     Yes 288 (11.23) 2 (0.45) 17 (1.53)   12 (6.19) 257 (93.8)   
Pre-existing condition: Metastatic/Hematologic Malignancy <0.001 
     No 2422 (94.46) 436 (98.2) 988 (88.93) 539 (99.63) 185 (95.36) 274 (100)   
     Yes 142 (5.54) 8 (1.8) 123 (11.07) 2 (0.37) 9 (4.64)  0 (0.00)   
Pulse Rhythm 0.7617 
     AIVR (Accelerated 
Idioventricular 
Rhythm) 
515 (81.36) 88 (80.00) 217 (80.97) 135 (81.82) 38 (90.48) 37 (77.08)   
     Bradycardia 6 (0.95) 1 (0.91) 1 (0.37) 4 (2.42)  0 (0.00)  0 (0.00)   
     Pacemaker 48 (7.58) 8 (7.27) 19 (7.09) 13 (7.88) 3 (7.14) 5 (10.42)   
     SVT 5 (0.79)   3 (1.12) 1 (0.61)  0 (0.00) 1 (2.08)   
     Sinus 14 (2.21) 2 (1.82) 6 (2.24) 3 (1.82)  0 (0.00) 3 (6.25)   
     VT with a Pulse 5 (0.79) 1 (0.91) 3 (1.12) 1 (0.61)  0 (0.00)  0 (0.00)   
     Unknown 40 (6.32) 10 (9.09) 19 (7.09) 8 (4.85) 1 (2.38) 2 (4.17)   
Pulse Sequence 0.001 
     Pulseless 1933 (75.39) 334 (75.23) 845 (76.06) 376 (69.5) 152 (78.35) 226 (82.48)   
     Pulse THEN 
Pulseless 
631 (24.61) 110 (24.77) 266 (23.94) 165 (30.5) 42 (21.65) 48 (17.52)   
Prior CPA <0.001 
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     Pre-Hospital 
(precipitating this 
admission) 
247 (9.63) 45 (10.14) 108 (9.72) 11 (2.03) 10 (5.15) 73 (26.64)   
     Other (previous 
admission, same 
or other hospital) 
103 (4.02) 34 (7.66) 41 (3.69) 17 (3.14) 8 (4.12) 3 (1.09)   
     Both 15 (0.59) 4 (0.9) 7 (0.63) 2 (0.37)  0 (0.00) 2 (0.73)   
     None/None 
Documented 
2199 (85.76) 361 (81.31) 955 (85.96) 511 (94.45) 176 (90.72) 196 (71.53)   
Prior Emergency Department Discharge within 24 hours <0.001 
     No 606 (75.47) 102 (76.69) 223 (67.58) 198 (97.54) 47 (83.93) 36 (44.44)   
     Yes 197 (24.53) 31 (23.31) 107 (32.42) 5 (2.46) 9 (16.07) 45 (55.56)   
First Pulseless Rhythm <0.001 
     Asystole 981 (38.26) 164 (36.94) 508 (45.72) 133 (24.58) 83 (42.78) 93 (33.94)   
     PEA 910 (35.49) 138 (31.08) 341 (30.69) 250 (46.21) 69 (35.57) 112 (40.88)   
     Pulseless VF 207 (8.07) 58 (13.06) 55 (4.95) 61 (11.28) 11 (5.67) 22 (8.03)   
     Pulseless VT 130 (5.07) 28 (6.31) 44 (3.96) 34 (6.28) 3 (1.55) 21 (7.66)   
     Unknown 336 (13.1) 56 (12.61) 163 (14.67) 63 (11.65) 28 (14.43) 26 (9.49)   
Instrument: Invasive Airway <0.001 
     No 991 (38.65) 231 (52.03) 494 (44.46) 138 (25.51) 76 (39.18) 52 (18.98)   
     Yes 1573 (61.35) 213 (47.97) 617 (55.54) 403 (74.49) 118 (60.82) 222 (81.02)   
Instrument: Apnea Monitor  <0.001 
     No 2289 (89.27) 407 (91.67) 1024 (92.17) 430 (79.48) 176 (90.72) 252 (91.97)   
     Yes 275 (10.73) 37 (8.33) 87 (7.83) 111 (20.52) 18 (9.28) 22 (8.03)   
Instrument: Pacemaker <0.001 
     No 2399 (93.56) 415 (93.47) 1103 (99.28) 415 (76.71) 192 (98.97) 274 (100)   
     Yes 165 (6.44) 29 (6.53) 8 (0.72) 126 (23.29) 2 (1.03)  0 (0.00)   
Instrument: Pulse Oximeter <0.001 
     No 371 (14.47) 85 (19.14) 216 (19.44) 24 (4.44) 15 (7.73) 31 (11.31)   
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     Yes 2193 (85.53) 359 (80.86) 895 (80.56) 517 (95.56) 179 (92.27) 243 (88.69)   
Instrument: Vascular Access IO 0.109 
     No 2529 (98.63) 438 (98.65) 1093 (98.38) 539 (99.63) 192 (98.97) 267 (97.45)   
     Yes 35 (1.37) 6 (1.35) 18 (1.62) 2 (0.37) 2 (1.03) 7 (2.55)   
Instrument: Vascular Access Peripheral Vein  0.1136 
     No 2003 (78.12) 354 (79.73) 885 (79.66) 402 (74.31) 147 (75.77) 215 (78.47)   
     Yes 561 (21.88) 90 (20.27) 226 (20.34) 139 (25.69) 47 (24.23) 59 (21.53)   
Instrument: Vascular Access UAC  <0.001 
     No 2538 (98.99) 439 (98.87) 1109 (99.82) 523 (96.67) 193 (99.48) 274 (100)   
     Yes 26 (1.01) 5 (1.13) 2 (0.18) 18 (3.33) 1 (0.52)  0 (0.00)   
Instrument: Assisted Or Mechanical Ventilator <0.001 
     No 964 (37.60) 214 (48.20) 485 (43.65) 136 (25.14) 72 (37.11) 57 (20.80)   
     Yes 1600 (62.40) 230 (51.80) 626 (56.35) 405 (74.86) 122 (62.89) 217 (79.2)   
Instrument: Supplemental Oxygen   0.001 
     No 2034 (79.33) 324 (72.97) 898 (80.83) 432 (79.85) 148 (76.29) 232 (84.67)   
     Yes 530 (20.67) 120 (27.03) 213 (19.17) 109 (20.15) 46 (23.71) 42 (15.33)   
Instrument: Continuous Sedative Narcotic <0.001 
     No 2330 (90.87) 421 (94.82) 1036 (93.25) 432 (79.85) 179 (92.27) 262 (95.62)   
     Yes 234 (9.13) 23 (5.18) 75 (6.75) 109 (20.15) 15 (7.73) 12 (4.38)   
Instrument: Conscious Sedation   0.4902 
     No 2466 (96.18) 427 (96.17) 1071 (96.4) 518 (95.75) 183 (94.33) 267 (97.45)   
     Yes 98 (3.82) 17 (3.83) 40 (3.6) 23 (4.25) 11 (5.67) 7 (2.55)   
Instrument: IVIO Continuous Vasoactive Agents <0.001 
     No 1552 (60.53) 299 (67.34) 767 (69.04) 192 (35.49) 142 (73.2) 152 (55.47)   
     Yes 1012 (39.47) 145 (32.66) 344 (30.96) 349 (64.51) 52 (26.8) 122 (44.53)   
Management: Cardiopulmonary Bypass <0.001 
     No 2393 (93.33) 412 (92.79) 1084 (97.57) 436 (80.59) 187 (96.39) 274 (100)   
     Yes 171 (6.67) 32 (7.21) 27 (2.43) 105 (19.41) 7 (3.61)  0 (0.00)   
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Management: Thoracentesis 0.016 
     No 2536 (98.91) 443 (99.77) 1094 (98.47) 536 (99.08) 189 (97.42) 274 (100)   
     Yes 28 (1.09) 1 (0.23) 17 (1.53) 5 (0.92) 5 (2.58)  0 (0.00)   
Management: Pericardiocentesis 0.292 
     No 2511 (97.93) 432 (97.3) 1090 (98.11) 534 (98.71) 187 (96.39) 268 (97.81)   
     Yes 53 (2.07) 12 (2.7) 21 (1.89) 7 (1.29) 7 (3.61) 6 (2.19)   
Management: Central Venous Line Inserted 0.014 
     No 2410 (93.99) 405 (91.22) 1045 (94.06) 522 (96.49) 180 (92.78) 258 (94.16)   
     Yes 154 (6.01) 39 (8.78) 66 (5.94) 19 (3.51) 14 (7.22) 16 (5.84)   
Management: Needle Thoracostomy 0.031 
     No 2493 (97.23) 435 (97.97) 1074 (96.67) 535 (98.89) 186 (95.88) 263 (95.99)   
     Yes 71 (2.77) 9 (2.03) 37 (3.33) 6 (1.11) 8 (4.12) 11 (4.01)   
Management: Transcutaneous Pacemaker <0.001 
     No 2435 (94.97) 412 (92.79) 1075 (96.76) 495 (91.5) 185 (95.36) 268 (97.81)   
     Yes 129 (5.03) 32 (7.21) 36 (3.24) 46 (8.5) 9 (4.64) 6 (2.19)   
Management: Blood Transfusion  <0.001 
     No 2264 (88.3) 408 (91.89) 1025 (92.26) 444 (82.07) 166 (85.57) 221 (80.66)   
     Yes 300 (11.7) 36 (8.11) 86 (7.74) 97 (17.93) 28 (14.43) 53 (19.34)   
Management: Chest Tube Inserted <0.001 
     No 2462 (96.02) 440 (99.1) 1058 (95.23) 526 (97.23) 184 (94.85) 254 (92.7)   
     Yes 102 (3.98) 4 (0.9) 53 (4.77) 15 (2.77) 10 (5.15) 20 (7.3)   
Drug: Other Alkalinizing Agent 0.019 
     No 2530 (98.67) 438 (98.65) 1089 (98.02) 540 (99.82) 190 (97.94) 273 (99.64)   
     Yes 34 (1.33) 6 (1.35) 22 (1.98) 1 (0.18) 4 (2.06) 1 (0.36)   
Drug: Amiodarone <0.001 
     No 2393 (93.33) 394 (88.74) 1051 (94.6) 502 (92.79) 185 (95.36) 261 (95.26)   
     Yes 171 (6.67) 50 (11.26) 60 (5.4) 39 (7.21) 9 (4.64) 13 (4.74)   
Drug: Any Antiarrhythmic <0.001 
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     No 2144 (83.62) 343 (77.25) 961 (86.5) 435 (80.41) 170 (87.63) 235 (85.77)   
     Yes 420 (16.38) 101 (22.75) 150 (13.5) 106 (19.59) 24 (12.37) 39 (14.23)   
Drug: Atropine <0.001 
     No 1493 (58.23) 257 (57.88) 610 (54.91) 384 (70.98) 109 (56.19) 133 (48.54)   
     Yes 1071 (41.77) 187 (42.12) 501 (45.09) 157 (29.02) 85 (43.81) 141 (51.46)   
Drug: Sodium Bicarbonate <0.001 
     No 969 (37.79) 155 (34.91) 442 (39.78) 160 (29.57) 85 (43.81) 127 (46.35)   
     Yes 1595 (62.21) 289 (65.09) 669 (60.22) 381 (70.43) 109 (56.19) 147 (53.65)   
Drug: Calcium Chloride/Calcium Gluconate <0.001 
     No 1350 (52.65) 234 (52.7) 629 (56.62) 188 (34.75) 110 (56.7) 189 (68.98)   
     Yes 1214 (47.35) 210 (47.3) 482 (43.38) 353 (65.25) 84 (43.3) 85 (31.02)   
Drug: Dextrose Bolus <0.001 
     No 2409 (93.95) 409 (92.12) 1029 (92.62) 524 (96.86) 180 (92.78) 267 (97.45)   
     Yes 155 (6.05) 35 (7.88) 82 (7.38) 17 (3.14) 14 (7.22) 7 (2.55)   
Drug: Dobutamine 0.0029 
     No 2432 (94.85) 408 (91.89) 1052 (94.69) 515 (95.19) 191 (98.45) 266 (97.08)   
     Yes 132 (5.15) 36 (8.11) 59 (5.31) 26 (4.81) 3 (1.55) 8 (2.92)   
Drug: Dopamine <0.001 
     No 1923 (75) 342 (77.03) 841 (75.7) 364 (67.28) 161 (82.99) 215 (78.47)   
     Yes 641 (25) 102 (22.97) 270 (24.3) 177 (32.72) 33 (17.01) 59 (21.53)   
Drug: Epinephrine Bolus 0.205 
     No 296 (11.54) 57 (12.84) 124 (11.16) 57 (10.54) 31 (15.98) 27 (9.85)   
     Yes 2268 (88.46) 387 (87.16) 987 (88.84) 484 (89.46) 163 (84.02) 247 (90.15)   
Drug: FluidBolus 0.62 
     No 1511 (58.93) 273 (61.49) 651 (58.6) 321 (59.33) 114 (58.76) 152 (55.47)   
     Yes 1053 (41.07) 171 (38.51) 460 (41.4) 220 (40.67) 80 (41.24) 122 (44.53)   
Drug: Magnesium Sulfate 0.049 
     No 2414 (94.15) 413 (93.02) 1049 (94.42) 500 (92.42) 189 (97.42) 263 (95.99)   
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     Yes 150 (5.85) 31 (6.98) 62 (5.58) 41 (7.58) 5 (2.58) 11 (4.01)   
Drug: Norepinephrine <0.001 
     No 2394 (93.37) 432 (97.3) 1029 (92.62) 522 (96.49) 178 (91.75) 233 (85.04)   
     Yes 170 (6.63) 12 (2.7) 82 (7.38) 19 (3.51) 16 (8.25) 41 (14.96)   
Drug: Neuromuscular Block Muscle Relax   <0.001 
     No 2417 (94.27) 414 (93.24) 1066 (95.95) 486 (89.83) 183 (94.33) 268 (97.81)   
     Yes 147 (5.73) 30 (6.76) 45 (4.05) 55 (10.17) 11 (5.67) 6 (2.19)   
Drug: Sedative Induction Agent  <0.001 
     No 2335 (91.07) 395 (88.96) 1044 (93.97) 456 (84.29) 174 (89.69) 266 (97.08)   
     Yes 229 (8.93) 49 (11.04) 67 (6.03) 85 (15.71) 20 (10.31) 8 (2.92)   
Teach <0.001 
     Primary 1629 (66.19) 279 (65.03) 633 (59.66) 405 (77.14) 132 (70.21) 180 (69.77)   
     Secondary 605 (24.58) 104 (24.24) 303 (28.56) 104 (19.81) 41 (21.81) 53 (20.54)   
     Tertiary 227 (9.22) 46 (10.72) 125 (11.78) 16 (3.05) 15 (7.98) 25 (9.69)   
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Table 2. Outcome for each illness category 
  Discharge Survival ALL 
Dead Alive 
N (%) N (%) N 
Illness Category       
     Medical, cardiac 306 (68.92) 138 (31.08) 444 
     Medical, noncardiac 832 (74.89) 279 (25.11) 1111 
     Surgical, cardiac 329 (60.81) 212 (39.19) 541 
     Surgical, noncardiac 119 (61.34) 75 (38.66) 194 
     Trauma 246 (89.78) 28 (10.22) 274 
 
 
 
 
Table 3. Outcome for each chest compression category 
  Discharge Survival ALL 
Dead Alive 
N (%) N (%) N 
Compression category 
   0-15 561 (54.05) 477 (45.95) 1038 
16-35 636 (82.38) 136 (17.62) 772 
>35 635 (84.22) 119 (15.78) 754 
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3.2 GAM ANALYSIS 
A GAM analysis was performed with survival status as the dependent variable and 
continuous chest compression duration (minutes) as the independent variable. The model used 
the spline smoother. Figure 2 showed the graph of chest compression duration and the smooth 
function. The curve of the smooth function approached zero at about 15 minutes and 65 minutes 
of chest compression duration. The slope of the curve changed at about 35 minutes and 140 
minutes of compression duration. Large variation of the smooth function estimate after 50 
minutes of chest compression indicated that the outcome varied as the compression duration 
increased and that the number of subjects may be very small. Therefore, the cutoff points after 50 
minutes of chest compression were ignored. The categories of the compression duration were 
determined as 0-15, 16-35, and more than 35 minutes.  
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Figure 2. Generalized Additive Model based on chest compression duration of all subjects 
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3.3 NRI ANALYSIS 
The net reclassification index (NRI) was used to determine the independent covariates for 
the model to predict the survival outcome. The base model was determined by expert opinions. 
The chosen variables were illness categories, chest compression duration, pulse rhythm on visit, 
age groups, event location, weekend on visit, daytime on visit, bypass procedure, calcium 
gluconate injection, previous septicemia episode, previous renal insufficient condition, and use 
of continuous vasoactive agents. All the above variables must be in the predictive model. 
Table 4 showed the NRI test results. The candidate variables were selected based on the 
expert opinions and the results of descriptive statistics in table 1. The variables being statistically 
different across the illness categories were tested by NRI. Only variables with p-value <0.05 and 
with positive NRI, indicating that they provided positive prediction toward survival, were 
included in the final model. The variable of prior major trauma was excluded from the final 
model because it was closely related to one of the illness categories, “Trauma”. Excluding this 
variable also avoided the problem of collinearity. In addition to the base model, five more 
variables were added into the final model. These five variables were use of sodium bicarbonate, 
prior cardiopulmonary arrest, use of apnea monitor, use of pulse monitor, and pre-existing 
condition of hypotension/hypoperfusion.  
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Table 4. NRI and test results for all possible covariates 
  
New variable Label NRI p-value 
adm_cpcp Pediatric cerebral performance category on 
admission 
0.0268 0.1720 
rx_bicar Drug: Sodium Bicarbonate 0.0549       0.0404 
prec_t Pre-existing condition: 
Metastatic/Hematologic Malignancy 
0.0231       0.0890 
rx_Epineph Drug: Epinephrine -0.0220      0.3441 
cpa_pri Prior cardiopulmonary arrest (CPA) 0.0659       0.0016 
ipa_apne Instrument: Apnea monitor 0.0592       0.0024 
rx_atro Drug: Atropine 0.0422       0.0533 
rx_dex Drug: Dextrose 0.0200       0.0941 
cau_o Cause: Conscious sedation 0.0071       0.3188 
Hisp Hispanic -0.0016      0.8053 
ipa_puls Instrument: Pulse oxymeter 0.0493       0.0090 
cau_l Cause: Inadequate natural airway -0.0054       0.6559 
nrx_tran Management: blood transfusion -0.0085       0.5241 
prec_i Pre-existing condition: Hepatic insufficiency 0.0088       0.3773 
prec_s Pre-existing condition: Major trauma 0.1174       0.0000 
ipa_pace Instrument: Pacemaker 0.0283       0.0735 
cau_b Pre-existing condition: 
Hypotension/hypoperfusion 
0.0274       0.1223 
ipa_vent Instrument: Assisted or mechanical 
ventilator 
0.0291       0.0926 
cau_d Cause: Acute pulmonary edema 0.0131       0.1135 
cau_j Cause: Invasive airway displacement 0.0022       0.7621 
cau_5 Cause: Drug overdose 0.0052       0.2373 
pul_seq Pulse sequence -0.0027       0.7619 
rx_norep Drug: Norepinephrine 0.0036       0.6688 
ipa_air Instrument: Invasive airway 0.0115       0.4264 
Race Race -0.0011      0.9075 
prec_f Pre-existing condition: 
Hypotension/Hypoperfusion 
0.0501      0.0013 
prec_j Pre-existing condition: Metabolic electrolyte 
abnormality 
-0.0137     0.2153 
prec_m Pre-existing condition: Baseline depression 
of CNS function 
-0.0257       0.0527 
prec_2+prec_3 Pre-existing condition: Cardiac malformation -0.0120       0.2256 
ipa_vape Instrument: Vascular access peripheral vein -0.0005       0.8594 
ipa_vaio Instrument: Vascular access IO -0.0000       0.9973 
ipa_vaua Instrument: Vascular access UAC 0.0027       0.6973 
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ipb_sed2 Instrument: Continuous sedative narcotics 0.0011       0.8623 
ipb_anti Instrument: Continuous antiarrhythmics -0.0019       0.8929 
ipb_oxy Instrument: Supplemental oxygen 0.0027       0.6631 
ipb_seda Instrument: Conscious sedation -0.0087       0.4215 
ed_pri Prior ED discharge within 24 hours -0.0094       0.6588 
subj_ty Subject types -0.0115       0.2017 
cau_h Cause: Metabolic electrolyte abnormality -0.0167       0.2345 
cau_m Cause: Inadequate invasive airway 0.0038       0.5924 
cau_r Cause: Hypothermia -0.0016       0.7839 
inv_a Invasive airway insertion -0.0217       0.0261 
inv_b Invasive airway reinsertion 0.0063       0.6218 
inv_c Invasive airway already in place 0.0003       0.9879 
Witness Witness present 0.0200       0.1829 
Witnessormonitor Witness or monitor 0.0184       0.1406 
rx_fliud Drug: Fluid bolus -0.0263       0.0648 
rx_dopa Drug: Dopamine -0.0178       0.1290 
rx_sedat Drug: Sedation 0.0011      0.9227 
rx_magne Drug: Magnesium sulfate 0.0027       0.7225 
rx_amiod Drug: Amiodarone 0.0003       0.9732 
rx_relax Drug: Muscle relaxant 0.0047       0.6259 
rx_dobut Drug: Dobutamine -0.0033       0.6002 
rx_alko Drug: Alkalinizing agent -0.0030       0.5415 
nrx_line Management: Central venous line insertion 0.0088       0.0672 
nrx_need Management: Needle thoracostomy -0.0093       0.1414 
nrx_pace Management: Pacemaker transcutaneous -0.0060       0.2890 
nrx_cent Management: Pericardiocentesis -0.0047       0.2911 
nrx_cen2 Management: Thoracentesis -0.0000       0.9986 
 
  
Table 4 Continued 
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3.4 REGRESSION COEFFICIENTS FROM THE THREE MODELS 
 
This study aimed to evaluate the association of illness categories with survival across 
different compression duration groups. The hypothesis was that the relationship of illness and 
survival was modified by compression duration. Interaction of compression duration groups and 
illness categories was included in the regression model. Though the type 3 analysis of effects for 
the interaction term was not statistically significant, several individual levels of the interaction 
term were statistically significant. Therefore, the interaction term was kept in the model.  
Logistic regression, generalized estimating equation (GEE), and generalized linear mixed 
model (GLMM) were used for the analysis of all eligible subjects. Four different correlation 
structures, including independent, exchangeable, autoregressive, and unstructured, working 
correlation structures were used in the GEE model. Quasilikelihood under the independence 
model criterion (QIC) was used to select the most appropriate working correlation structure. 
Table 5 showed the QIC values of the models with the four working correlation structures. 
Though the model with the first order of autoregressive working correlation structure had the 
smallest QIC, the QIC values for all correlation structures were similar. The exchangeable 
correlation structure is more appropriate for the characteristics of the data. Therefore, the 
coefficients in table 6 and odds ratios in table 7 were obtained from the GEE model with 
exchangeable working correlation structure.  
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Table 5. QIC for different working correlation structure 
 
Working correlation structure Criterion Value 
Independent QIC 2437.1185 
Exchangeable QIC 2437.7513 
Autoregressive (1) QIC 2436.9282 
Unstructured QIC 2439.5321 
 
 
Table 6 summarized the estimates of parameters from the logistic regression, GEE model, 
and GLMM model. In general, the estimates of parameters were similar among the three models. 
Though the standard deviation of most estimates was slightly higher in the GEE and GLMM, the 
conclusion derived from the three models are similar. In the regression model, the type 3 analysis 
of effects showed significant effects for most covariates, except for time and weekend of events. 
However, the expert opinion preferred keeping them in the final model. The two major interests 
of the study, compression duration groups and illness categories, were significantly related to 
survival of the subjects. When inspecting the individual covariates, the odds of survival were not 
significantly different between the age group of 1 -8 years and the age group of younger than 1 
month for the logistic model and GLMM. However, GEE showed significant different survival 
odds between the two groups. On the contrary, the odds of survival for the subjects experiencing 
SCA in the procedure room was significantly different from the odds of survival for the subjects 
experiencing SCA in the ICU for the logistic model and GLMM, but not for the GEE model.     
37 
 
 
 
Table 6. Coefficients of covariates in logistic regression, GEE, and Mixed model (random intercept) 
 
    Logistic regression GEE (AR1) Mixed model 
Covariates Estimate StdErr p-value Estimate Stderr p-value Estimate StdErr p-value 
 Intercept   -2.3116 0.4108 <.0001 -2.3446 0.3681 <.0001 -2.3418 0.4134 <.0001 
Compression duration 
categories 
            
    0-15   1.7218 0.2297 <.0001 1.7445 0.2681 <.0001 1.7188 0.2306 <.0001 
    16-35   0.6396 0.2458 0.0093 0.6497 0.2561 0.0112 0.6323 0.2464 0.0109 
Illness categories             
    Medical, cardiac 0.788 0.2987 0.0083 0.8213 0.3018 0.0065 0.7829 0.2996 0.0095 
    Surgical, cardiac 1.0413 0.2889 0.0003 1.0569 0.3265 0.0012 1.0612 0.2901 0.0003 
    General, surgical 0.0901 0.4959 0.8558 0.0516 0.3985 0.897 0.09467 0.4977 0.8493 
    Trauma -0.7196 0.7626 0.3454 -0.6818 0.774 0.3784 -0.7077 0.7636 0.3549 
Interaction of illness and 
compression duration 
            
    0-15 Medical, cardiac -0.3697 0.3628 0.3082 -0.4188 0.3696 0.2571 -0.3648 0.3638 0.3179 
    0-15 Surgical, cardiac -0.0265 0.3341 0.9367 -0.0883 0.3362 0.7929 -0.0245 0.3347 0.9418 
    0-15 General, 
surgical 
0.2122 0.5555 0.7024 0.2042 0.4479 0.6484 0.2074 0.5576 0.7105 
    0-15 Trauma -0.5565 0.8067 0.4903 -0.6195 0.8314 0.4562 -0.5676 0.8076 0.4835 
    16-35 Medical, cardiac -0.9794 0.4034 0.0152 -1.0398 0.3604 0.0039 -0.9617 0.4047 0.0190 
    16-35 Surgical, cardiac -0.3507 0.3727 0.3468 -0.3565 0.4087 0.3831 -0.3413 0.3731 0.3619 
    16-35 General, 
surgical 
0.4451 0.6218 0.4741 0.4897 0.5082 0.3352 0.4498 0.6238 0.4722 
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    16-35 Trauma -0.9734 0.935 0.2978 -0.9668 1.026 0.3461 -0.9685 0.9361 0.3028 
Pulse rhythm             
    Asystole -0.6823 0.1618 <.0001 -0.688 0.1653 <.0001 -0.6798 0.163 <.0001 
    PEA   -0.3575 0.1625 0.0278 -0.3591 0.1703 0.035 -0.3428 0.1653 0.0389 
    Pulseless VF -0.3336 0.2239 0.1362 -0.3463 0.235 0.1407 -0.3421 0.2248 0.1291 
    Pulseless VT -0.0971 0.2607 0.7095 -0.1131 0.2665 0.6714 -0.08988 0.2617 0.7315 
Age group             
    1 month - <1 year 0.5764 0.1554 0.0002 0.5812 0.1297 <.0001 0.5804 0.1559 0.0002 
    1 yr - <8yr 0.3214 0.1676 0.0552 0.3084 0.1351 0.0225 0.3212 0.1682 0.0572 
    8 yr - <18 yr 0.1856 0.1729 0.2832 0.1765 0.1822 0.3328 0.1921 0.1736 0.2694 
Weekend             
    Yes   0.0103 0.1118 0.9266 0.0233 0.1034 0.822 0.01298 0.1122 0.9081 
Time of Day             
    Day   0.0266 0.1125 0.8131 0.0358 0.1382 0.7955 0.02845 0.1128 0.8013 
Management: Bypass             
    Yes   0.9637 0.2189 <.0001 0.928 0.204 <.0001 0.9192 0.2206 0.0003 
Drug: Calcium gluconate             
    Yes   -0.3935 0.1235 0.0014 -0.412 0.1104 0.0002 -0.404 0.1247 0.0016 
Pre-existing condition: 
Septicemia 
            
    Yes   -0.5863 0.1697 0.0006 -0.5733 0.1669 0.0006 -0.591 0.1704 0.0008 
Pre-existing condition: 
Renal insufficiency 
            
    Yes   -0.7905 0.2095 0.0002 -0.7667 0.2427 0.0016 -0.7909 0.2102 0.0003 
Instrument: Continuous 
vasoactive agent  
            
    Yes   -0.766 0.1303 <.0001 -0.7883 0.1592 <.0001 -0.7809 0.1311 <.0001 
Event location             
    Emergency -0.1632 0.1804 0.3657 -0.1717 0.1836 0.3496 -0.1657 0.1822 0.3642 
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    General Inpatient 0.1318 0.1852 0.4767 0.1002 0.1883 0.5945 0.1359 0.186 0.4655 
    Procedure room 0.6002 0.2321 0.0097 0.5981 0.3195 0.0612 0.5962 0.2334 0.0113 
    Others   0.1375 0.308 0.6552 0.0881 0.2818 0.7545 0.1335 0.3105 0.6676 
Drug: Sodium bicarbonate             
    Yes   -0.6393 0.1192 <.0001 -0.6355 0.1468 <.0001 -0.6331 0.1199 <.0001 
Prior CPA             
    Both   0.2513 0.8401 0.7648 0.2689 0.7189 0.7084 0.2357 0.8425 0.7802 
    None/None Documented 1.0227 0.2385 <.0001 1.0483 0.2608 <.0001 1.0364 0.2395 <.0001 
    Other (previous 
admission, same or other 
hospital) 
1.2146 0.3395 0.0003 1.2395 0.3517 0.0004 1.2049 0.3408 0.0006 
Instrument: Apnea monitor             
    Yes   0.6097 0.1674 0.0003 0.6118 0.1781 0.0006 0.6106 0.1781 0.0016 
Instrument: Pulse oxymeter             
    Yes   0.2523 0.1704 0.1386 0.2679 0.1747 0.1251 0.2397 0.1719 0.166 
Pre-existing condition: 
Hypotension/Hypoperfusion 
            
    Yes   -0.3013 0.1186 0.0111 -0.2968 0.0968 0.0022 -0.2834 0.12 0.0201 
Table 6 Continued 
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3.5 ODDS RATIOS 
 
Table 7 showed the odds ratios of the other illness categories vs. the general medical 
condition in each compression duration group. In the group of chest compression less than 16 
minutes, patients with medical cardiac condition and with surgical cardiac condition had higher 
odds of survival compared to subjects with general medical condition. On the contrary, subjects 
with trauma were less likely to survive. In the group of chest compression duration between 16 
and 35 minutes, only subjects with a surgical cardiac condition had a better odds to survive 
compared to the subjects with a general medical condition. And the subjects with trauma still had 
the worse outcome. In the group of chest compression longer than 35 minutes, the subjects with a 
medical cardiac or with a surgical cardiac condition had a better outcome. Similar results can be 
obtained from GEE and GLMM models. In the group of chest compression less than 16 minutes, 
the odds of survival for the subjects with medical cardiac condition and for the subjects with 
general medical condition were not statistically different in the GLMM model; however, the 
odds ratios and their 95% confidence intervals were greater than 1 in the logistic model and GEE 
model. Comparing the estimates and the 95% confidence intervals of the results in the three 
models, they were still very similar and the lower limit of the confidence interval derived from 
GLMM was slightly smaller than 1. Therefore, we still concluded that the results from the three 
models were not significantly different. 
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Table 7. Odds ratios of illness categories for survival within each compression duration category for logistic regression, GEE, 
and mixed model 
 
  Logistic regression GEE Mixed Model 
Label OR LowerCL UpperCL OR LowerCL UpperCL OR LowerCL UpperCL 
Medical cardiac vs general medical <15 min 1.5194 1.0057 2.2955 1.4955 1.0204 2.1917 1.519 0.9998 2.3078 
surgical cardiac vs general medical <15 min 2.7588 1.8326 4.153 2.6344 1.8718 3.7077 2.8198 1.8569 4.2821 
surgical noncardiac vs general medical <15 min 1.353 0.8022 2.2819 1.2915 0.7797 2.1392 1.3527 0.7963 2.2979 
Trauma vs general medical <15 min 0.2791 0.1634 0.4769 0.2722 0.1505 0.4923 0.2794 0.1622 0.481 
Medical cardiac vs general medical 15-35 min 0.8258 0.4802 1.4201 0.8037 0.4741 1.3626 0.8362 0.4824 1.4496 
surgical cardiac vs general medical 15-35 min 1.995 1.1652 3.4156 2.0147 1.2798 3.1716 2.0541 1.1906 3.5439 
surgical noncardiac vs general medical 15-35 min 1.7078 0.8014 3.6394 1.7182 0.8221 3.591 1.7237 0.8012 3.7081 
Trauma vs general medical 15-35 min 0.184 0.06288 0.5381 0.1923 0.04938 0.7492 0.1871 0.06311 0.5546 
Medical cardiac vs general medical >35 min 2.199 1.2244 3.9491 2.2734 1.2584 4.1072 2.1877 1.2094 3.9576 
surgical cardiac vs general medical >35 min 2.8329 1.6081 4.9904 2.8775 1.5173 5.4569 2.8897 1.6278 5.1299 
surgical noncardiac vs general medical >35 min 1.0943 0.414 2.8924 1.0529 0.4822 2.2993 1.0993 0.4106 2.9428 
Trauma vs general medical >35 min 0.4869 0.1092 2.1708 0.5057 0.1109 2.3055 0.4928 0.1088 2.2327 
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3.6 PREDICTION MODEL 
The estimates of parameters were similar in logistic regression, GEE, and GLMM. To 
simplify the process of prediction, the predicted probability of survival was estimated based on 
the results of logistic regression. All variables selected by NRI were included in the model. 
Interaction of continuous chest compression duration and illness categories was included in the 
model. The average value of each covariate was used in the model for the prediction of the 
probability of survival.  
Figure 3 showed the predicted probability of survival for each illness category from 0 
minutes through 180 minutes of chest compression. Patients with a surgical cardiac condition 
had the best probability of survival. Within 10 minutes of chest compression, the survival 
probability for this group of patients was up to 50%. The probabilities of survival were similar in 
the beginning for subjects with a medical cardiac and a general medical condition. However, the 
probability dropped faster for the subjects with a general medical condition as the duration of 
chest compression increased. Though patients with a general surgical condition had a higher 
probability of survival in the beginning compared to those who with a general medical condition, 
the probabilities were tied after 70 minutes of chest compression. Both groups of patients had a 
survival probability of less than 10%. 
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Figure 3. Predicated probability of survival for each illness category 
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4.0 DISCUSSION 
4.1 CONCLUSION 
4.1.1 Generalized Additive Model (GAM) analysis 
Though continuous variables may provide more information, they may not be practical in 
the clinical setting. A GAM can appropriately categorize continuous predictors based on the 
relationship of the predictors and the outcome through a nonparametric smoothing function. This 
method determined several cutoff points of chest compression duration for this data set. However, 
not all cutoff points should be used. The variance increased dramatically for longer chest 
compression duration because fewer cases received such a long duration of chest compression. 
The slope of the curve did not change dramatically after 35 minutes of chest compression 
duration. Therefore, the cutoff points after 35 minutes were not used in this study. 
   
4.1.2 Net Reclassification Index (NRI) analysis 
Many characteristics of the patients were significantly different across the disease groups 
(Table 1). Though they can be included in the predictive model, the problems of over-fitting and 
computational demand may compromise the feasibility of the models. Also, the final model with 
too many predictors is not practical in the clinical setting. Using the NRI to determine the most 
appropriate variables for prediction has become popular recently. This method can specifically 
select the variables predicting the desired outcome, but not predicting the opposite outcome. 
Therefore, the model determined by NRI can be more precise.  
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4.1.3 Logistic regression, Generalized Estimating Equation (GEE), and Generalized Linear 
Mixed Model (GLMM) analyses 
This study showed that estimates of parameters obtained from a logistic regression model, a 
GEE model, and a GLMM were similar and the conclusion derived from the three modeling 
methods was the same. The hospital based registry data were considered as a clustered 
observational study design. The subjects within the same cluster were correlated because the 
clinical practice and patients’ characteristics may be similar within a specific cluster, but 
different from the other clusters. Both GEE and GLMM can deal with correlated data. However, 
the benefits of the two complicated methods were not confirmed in this study.     
Several factors may undermine the performance of GEE and GLMM. First, the sizes of 
clusters were diverse. Some clusters had hundreds of patients, but small sized clusters were more 
common in the data set. Therefore, subjects may be independent. Second, survival of SCA may 
mainly depend on appropriate CPR procedure and characteristics of subjects, but not on 
characteristics related to the hospitals. Therefore, the hospital effect is limited. Random effects 
may not be necessary to analyze data related to SCA patients.      
The methods for correlated data may not be necessary for problems that are mainly related 
to characteristics of patients but not depend on features of clusters.   
 
  
46 
 
4.2 PUBLIC HEALTH ASPECT 
The registry data that include comprehensive variables have been established for many 
healthcare problems. In order to explore the data appropriately and to derive clinically applicable 
inferences, a systematic process is necessary. This study demonstrated the process used to 
analyze hospital based registry data of SCA episodes.  
The process involves the categorization of observations for clinical application, the 
establishment of an appropriate model to predict outcome, and the computation of estimates 
through methods that take correlated data into consideration. The similar results from the three 
methods in this study may be caused by the specific entity of the health problem. Therefore, 
using estimates from logistic regression to predict probability of survival is appropriate. 
However, for the other health problems, it may be still necessary to consider the random effect 
related to the different hospitals.  
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